Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Business Wire

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Rio Tinto’s first Pilbara-made rail car built by Gemco in Karratha
From Rio Tinto
Via Business Wire
Tickers ASX:RIO
News headline image
Hotel Okura to Open The Okura Resort Hakone Gora in 2029
From Hotel Okura Co., Ltd.
Via Business Wire
News headline image
GoTyme Bank Launches Crypto Trading in the Philippines in Partnership with Alpaca
From Alpaca
Via Business Wire
News headline image
Gigaphoton Excimer Laser for Advanced Packaging Installed at Japanese Company
From Gigaphoton Inc.
Via Business Wire
News headline image
Sustainability Focus Session 2025
From Woodside Energy Group
Via Business Wire
Tickers ASX:WDS WDS
News headline image
Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies
From BeOne Medicines Ltd.
Via Business Wire
Tickers ONC
News headline image
National Fuel Gas Company Investigated for Breaches of Fiduciary Duty - Contact the DJS Law Group to Discuss Your Rights – NFG
From DJS Law Group
Via Business Wire
Tickers NFG
News headline image
Gartner Announces Gartner Finance Symposium/Xpo 2026 in Sydney
From Gartner
Via Business Wire
Tickers IT
News headline image
Halper Sadeh LLC Encourages Eagle Pharmaceuticals, Inc. Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via Business Wire
News headline image
Halper Sadeh LLC Encourages Lifecore Biomedical, Inc. Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via Business Wire
Tickers LFCR
News headline image
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH
From AOP Health
Via Business Wire
News headline image
Incyte’s First-in-Class mutCALR-Targeted Monoclonal Antibody, INCA033989, Granted Breakthrough Therapy Designation by U.S. FDA
From Incyte
Via Business Wire
Tickers INCY
News headline image
Incyte Announces New Positive Data for INCA033989, its First-In-Class mutCALR-Targeted Monoclonal Antibody, in Patients with Myelofibrosis Presented at ASH 2025
From Incyte
Via Business Wire
Tickers INCY
News headline image
Yescarta® Delivers Consistent Safety, Efficacy, and Quality of Life Benefits Across Broad Range of Relapsed/Refractory Large B-cell Lymphoma Patients in New Analysis at ASH 2025
From Gilead Sciences, Inc.
Via Business Wire
Tickers GILD
News headline image
Genmab Presents Pivotal Phase 3 Data from EPCORE® FL-1 Trial Demonstrating Clinical Benefit of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide (R2) in Patients with Relapsed or Refractory Follicular Lymphoma
From Genmab A/S
Via Business Wire
Tickers GMAB
News headline image
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future
From CoMotion
Via Business Wire
News headline image
Zai Lab Announces Updates to China’s National Reimbursement Drug List
From Zai Lab Limited
Via Business Wire
Tickers ZLAB
News headline image
Memphis Shines as Thousands Unite for St. Jude Memphis Marathon Weekend
From St. Jude Children’s Research Hospital
Via Business Wire
News headline image
Rosen Law Firm Encourages Klarna Group plc Investors to Inquire About Securities Class Action Investigation – KLAR
From The Rosen Law Firm, P.A.
Via Business Wire
Tickers KLAR
News headline image
HYMPAVZI® (marstacimab) Reduced Bleeds by 93% Compared to On-Demand Treatment in Adults and Adolescents with Hemophilia A or B with Inhibitors
From Pfizer Inc.
Via Business Wire
Tickers PFE
News headline image
Star Therapeutics Presents Interim Data from Phase 1/2 Multidose Study of VGA039 in Von Willebrand Disease, Demonstrating Substantial Bleed Reductions in All Patients, at ASH Annual Meeting
From Star Therapeutics
Via Business Wire
News headline image
TheOther Debuts Premium Matcha at an Intimate Art Basel Celebration in Miami Co-Hosted By Central Cee
From TheOther
Via Business Wire
News headline image
Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients with Relapsed and/or Refractory Multiple Myeloma
From Arcellx, Inc.
Via Business Wire
Tickers ACLX
News headline image
Kite’s Next-Generation Bicistronic CAR T-Cell Therapies Show Encouraging Phase 1 Results in Relapsed/Refractory B-Cell Lymphoma in New Data at ASH 2025
From Gilead Sciences, Inc.
Via Business Wire
Tickers GILD
News headline image
Kite Announces New Data for Pivotal iMMagine-1 Study at ASH 2025, Highlighting Anito-cel’s Opportunity in Relapsed or Refractory Multiple Myeloma
From Gilead Sciences, Inc.
Via Business Wire
Tickers GILD
News headline image
Worthington Steel Issues Statement Regarding Klöckner & Co SE
From Worthington Steel, Inc.
Via Business Wire
Tickers WS
News headline image
Orca Bio Presents New Clinical Data on Orca-T® in Older Patients Using Reduced Intensity Conditioning Plus New Analyses from the Precision-T Phase 3 Study at the 67th ASH Annual Meeting
From Orca Bio
Via Business Wire
News headline image
Genmab Announces Data From Multiple Clinical Trials Showing Treatment with Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)
From Genmab A/S
Via Business Wire
Tickers GMAB
News headline image
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera
From Takeda Pharmaceutical Company Limited
Via Business Wire
Tickers TAK
News headline image
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting
From Deciphera Pharmaceuticals Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.